Aanjaneya Lifecare inches up on getting nod for overseas expansion

09 Jan 2012 Evaluate

Aanjaneya Lifecare is currently trading at Rs. 484.50, up by 0.40 points or 0.08% from its previous closing of Rs. 484.10 on the BSE.

The scrip opened at Rs. 485.80 and has touched a high and low of Rs. 488.60 and Rs. 481.50 respectively. So far 1852 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 525.00 on 26-Dec-2011 and a 52 week low of Rs. 224.00 on 27-May-2011.

Last one week high and low of the scrip stood at Rs. 514.00 and Rs. 475.15 respectively. The current market cap of the company is Rs. 609.78 crore.

The promoters holding in the company stood at 60.24% while Institutions and Non-Institutions held 4.57% and 35.19% respectively. 

Aanjaneya Lifecare has received an approval for overseas expansion whereby it has decided to open subsidiary companies and offices in Singapore and UAE. The board at its meeting held on January 09, 2012 has approved for the same.

Further, the board has also authorized the managing director of the company, to negotiate the terms and conditions for acquisition of 100% assets and business of Apex Drugs & Intermediates.

Aanjaneya Lifecare is a leading research based integrated pharmaceutical company with established research, manufacturing and marketing capabilities.  It is R&D focused, has a multi product portfolio with state of the art manufacturing facilities, and is set to become a marketing conglomerate across the globe.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×